THOUSAND OAKS, CA: Biopharmaceutical company Amgen has named Judy Gawlik Brown as SVP of corporate affairs.
Brown is reporting to Robert Bradway, chairman and CEO. She is responsible for strategic communications across Amgen, including internal and external comms, issues management, and philanthropy, according to the leadership page on Amgen’s website.
"Amgen’s corporate affairs team provides tremendous value for the company by shaping, driving, and enhancing our reputation," Brown said via email. "I look forward to further growing our team’s capabilities, identifying new areas to leverage our strategic expertise, and cultivating our staff into a best-in-class communications function."
She has replaced Ray Jordan, who has served as SVP of corporate affairs since he joined Amgen in October 2012. Jordan announced plans to retire from Amgen last October and to transition from his role while continuing to serve Amgen into 2019. While at Amgen, Jordan led communications for an unprecedented six product launches over a six-year period, according to the website.
Before joining Amgen, Jordan led communications at Johnson & Johnson for nine years. He started J&J's first blog and enhanced the company's social media use during his tenure, as well as handling a range of other communications challenges. He was also routinely a member of PRWeek's Power List while at J&J.
Jordan was not immediately available for comment.
Brown joined Amgen in 2017 as SVP of global business solutions and finance. Joe Peter was hired for Brown’s previous position.
Previously, Brown worked at Perrigo Company as EVP of business operations and CFO. Before that, she held finance, global product development, and brand marketing leadership positions in Italy and the U.S. for Whirlpool. Brown began her career in the Chicago office of Ernst & Young and worked for the company in Germany in its audit and M&A practices, according to Amgen’s website.
Asked why Brown was moved from a financial role to the head comms position, an Amgen representative said that she has a diverse background. Brown established and oversaw both government and corporate affairs functions in previous roles, the spokesperson said.
Amgen’s total revenue increased 7% to $6.2 billion in Q4; and for the full-year 2018, total revenue rose 4% to $23.7 billion, with 3% product sales growth. While it posted better than expected quarterly earnings, it disappointed investors by saying it expects 2019 revenue to fall below estimates, according to CNBC.